Analysts have varying views on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CAMP is 2.64M, and currently, shorts hold a 14.66% of that float. The average trading volume for CAMP on May 22, 2025 was 255.95K shares.
CAMP) stock’s latest price update
The stock of CAMP4 Therapeutics Corp (NASDAQ: CAMP) has decreased by -11.21 when compared to last closing price of 2.23.Despite this, the company has seen a gain of 6.45% in its stock price over the last five trading days. globenewswire.com reported 2025-05-16 that Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes
CAMP’s Market Performance
CAMP4 Therapeutics Corp (CAMP) has seen a 6.45% rise in stock performance for the week, with a 1.54% gain in the past month and a -59.01% plunge in the past quarter. The volatility ratio for the week is 13.28%, and the volatility levels for the past 30 days are at 11.95% for CAMP. The simple moving average for the past 20 days is -2.74% for CAMP’s stock, with a -63.69% simple moving average for the past 200 days.
Analysts’ Opinion of CAMP
Piper Sandler, on the other hand, stated in their research note that they expect to see CAMP reach a price target of $18. The rating they have provided for CAMP stocks is “Overweight” according to the report published on November 05th, 2024.
JP Morgan gave a rating of “Overweight” to CAMP, setting the target price at $23 in the report published on November 05th of the previous year.
CAMP Trading at -33.74% from the 50-Day Moving Average
After a stumble in the market that brought CAMP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.90% of loss for the given period.
Volatility was left at 11.95%, however, over the last 30 days, the volatility rate increased by 13.28%. Over the last 50 days, in opposition, the stock is trading -63.93% lower at present.
During the last 5 trading sessions, CAMP rose by +6.45%, in comparison to the 20-day moving average, which settled at $2.04. In addition, CAMP4 Therapeutics Corp saw -62.07% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CAMP starting from Northpond Ventures II GP, LLC, who purchase 763,636 shares at the price of $11.00 back on Oct 15 ’24. After this action, Northpond Ventures II GP, LLC now owns 763,636 shares of CAMP4 Therapeutics Corp, valued at $8,399,996 using the latest closing price.
AH Equity Partners Bio I, L.L., the 10% Owner of CAMP4 Therapeutics Corp, purchase 727,272 shares at $11.00 during a trade that took place back on Oct 15 ’24, which means that AH Equity Partners Bio I, L.L. is holding 1,579,885 shares at $7,999,992 based on the most recent closing price.
Stock Fundamentals for CAMP
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.36 for the gross margin
The net margin for CAMP4 Therapeutics Corp stands at -0.5. The total capital return value is set at -0.03.
Based on CAMP4 Therapeutics Corp (CAMP), the company’s capital structure generated 0.94 points at debt to capital in total, while cash flow to debt ratio is standing at -0.1.
Currently, EBITDA for the company is -8.72 million with net debt to EBITDA at -22.76. When we switch over and look at the enterprise to sales, we see a ratio of 1.28. The receivables turnover for the company is 2.25for trailing twelve months and the total asset turnover is 0.49. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.02.
Conclusion
In conclusion, CAMP4 Therapeutics Corp (CAMP) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
